Nurocor Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 57

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.33M

  • Investors
  • 4

Nurocor General Information

Description

Developer of digital clinical development tools designed for transforming document-based processes into structured data workflows. The company's platform supports protocol design, standards management, and digital asset governance through microservices and shared services like access control and audit trails, enabling pharmaceutical and life sciences organizations to accelerate study design, improve regulatory readiness and enhance collaboration across teams.

Contact Information

Website
www.nurocor.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3800 North Lamar
  • Suite 2064
  • Austin, TX 78756
  • United States
+1 (512)
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 3800 North Lamar
  • Suite 2064
  • Austin, TX 78756
  • United States
+1 (512)

Nurocor Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurocor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 21-May-2025 $2.33M Completed Generating Revenue
5. Later Stage VC 16-Oct-2024 Completed Generating Revenue
4. Debt - General 01-Feb-2022 Completed Generating Revenue
3. Early Stage VC (Series B) 21-Jun-2021 Completed Generating Revenue
2. Debt - PPP 27-Apr-2020 $519K Completed Generating Revenue
1. Early Stage VC 11-May-2017 Completed Generating Revenue
To view Nurocor’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Nurocor Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Nurocor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4771634-A1 Specimen management for clinical research study systems Pending 30-Aug-2023
US-20250078966-A1 Specimen management for clinical research study systems Pending 30-Aug-2023
WO-2025049916-A1 Specimen management for clinical research study systems Inactive 30-Aug-2023
EP-4569518-A1 Code generator for clinical research study systems Pending 08-Aug-2022
US-12362072-B2 Code generator for clinical research study systems Active 08-Aug-2022 G16H70/20
To view Nurocor’s complete patent history, request access »

Nurocor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurocor Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Simulations Plus Corporation Minority
Frontier Venture Capital Venture Capital Minority
Recurring Capital Partners Growth/Expansion Minority
Archer Venture Capital Secondary Buyer Minority
To view Nurocor’s complete investors history, request access »

Ready to get started?

Request a free trial

Nurocor FAQs

  • When was Nurocor founded?

    Nurocor was founded in 2017.

  • Where is Nurocor headquartered?

    Nurocor is headquartered in Austin, TX.

  • What is the size of Nurocor?

    Nurocor has 57 total employees.

  • What industry is Nurocor in?

    Nurocor’s primary industry is Enterprise Systems (Healthcare).

  • Is Nurocor a private or public company?

    Nurocor is a Private company.

  • What is Nurocor’s current revenue?

    The current revenue for Nurocor is .

  • How much funding has Nurocor raised over time?

    Nurocor has raised $7.63M.

  • Who are Nurocor’s investors?

    Simulations Plus, Frontier Venture Capital, Recurring Capital Partners, and Archer Venture Capital have invested in Nurocor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process